Abeona Therapeutics (ABEO) Amortizatization of Intangibles (2019 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Amortizatization of Intangibles of -$13000.0 for Q1 2026, up 97.14% year-over-year from -$6594.2 in Q1 2025, and up 98.11% quarter-over-quarter from -$687000.0 in Q4 2025.
Powered by 
Analysis
Abeona Therapeutics (ABEO) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Abeona Therapeutics' Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at -$13000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 97.14% year-over-year to -$13000.0; the TTM figure through Mar 2026 stood at -$447000.0 (up 43.42% YoY), while the FY2025 annual figure was -$889000.0, down 222.1% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at -$13000.0, up from -$687000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $227000.0 in Q4 2023, with the low at -$687000.0 in Q4 2025.
- The 5-year median for Amortizatization of Intangibles is $29000.0 (2022), against an average of -$41470.6.
- Peak annual rise in Amortizatization of Intangibles reached 2257.14% in 2025, while the deepest fall reached 871.19% in 2025.
- Abeona Therapeutics' Amortizatization of Intangibles stood at $174000.0 in 2022, then jumped by 30.46% to $227000.0 in 2023, then sank by 197.8% to -$222000.0 in 2024, then plunged by 209.46% to -$687000.0 in 2025, then soared by 98.11% to -$13000.0 in 2026.
- Business Quant data shows ABEO's Amortizatization of Intangibles at -$13000.0 in Q1 2026, -$687000.0 in Q4 2025, and $88000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Abeona Therapeutics | 342.29 Mn | 195.46 Mn | 7.20 Mn | 168,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 168,000.00 |
| Mar 31, 2026 | 179,000.00 |
| Dec 31, 2025 | 229,000.00 |
| Sep 30, 2025 | 280,000.00 |
| Jun 30, 2025 | 960,000.00 |
| Mar 31, 2025 | -455,000.00 |
| Dec 31, 2024 | 237,000.00 |
| Sep 30, 2024 | 235,000.00 |
| Jun 30, 2024 | 198,000.00 |
| Mar 31, 2024 | 233,000.00 |
| Dec 31, 2023 | 230,000.00 |
| Sep 30, 2023 | 230,000.00 |
| Jun 30, 2023 | 223,000.00 |
| Mar 31, 2023 | 227,000.00 |
| Dec 31, 2022 | 280,000.00 |
| Sep 30, 2022 | 305,000.00 |
| Jun 30, 2022 | 597,000.00 |
| Mar 31, 2022 | 302,000.00 |
| Dec 31, 2021 | 389,000.00 |
| Sep 30, 2021 | 282,000.00 |